Gain Therapeutics, Inc. stock is up 6.37% since 30 days ago. The next earnings date is Mar 21, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 December’s closed higher than November. 100% of analysts rate it a buy.
Gain Therapeutics, Inc. engages in developing therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company was founded in 2017 and is based in Bethesda, Maryland.